Related Experiment Video
Updated: Jan 4, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Growth Factor-Dependent and -Independent Activation of mTORC2
Jonas R Knudsen1, Andreas M Fritzen1, David E James2
1Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Abstract:
The target of rapamycin complex 2 (TORC2) was discovered in 2002 in budding yeast. Its mammalian counterpart, mTORC2, was first described in 2004. Soon thereafter it was demonstrated that mTORC2 directly phosphorylates Akt on Ser473, ending a long search for the elusive 'second' insulin-responsive Akt kinase. In this review we discuss key evidence pertaining to the subcellular localization of mTORC2, highlighting a spatial heterogeneity that relates to mTORC2 activation. We summarize current models for how growth factors (GFs), such as insulin, trigger mTORC2 activation, and we provide a comprehensive discussion focusing on a new exciting frontier, the molecular mechanisms underpinning GF-independent activation of mTORC2.
Insights
Mammalian target of rapamycin complex 2 (mTORC2) phosphorylates Akt, a key step in insulin signaling. This review explores mTORC2
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Biochemistry
Background:
- The target of rapamycin complex 2 (TORC2) was identified in 2002, with its mammalian homolog, mTORC2, described in 2004.
- mTORC2 was found to directly phosphorylate Akt at Ser473, identifying the long-sought second insulin-responsive Akt kinase.
Purpose of the Study:
- To review the subcellular localization of mTORC2 and its relation to activation.
- To summarize current models of growth factor-mediated mTORC2 activation.
- To explore novel mechanisms of growth factor-independent mTORC2 activation.
Main Methods:
- Review of existing scientific literature and experimental evidence.
- Analysis of data pertaining to mTORC2 localization and function.
- Synthesis of current understanding and identification of research frontiers.
Main Results:
- Evidence suggests spatial heterogeneity in mTORC2 localization influences its activation.
- Growth factors, like insulin, trigger mTORC2 activation through specific signaling pathways.
- Emerging research focuses on mechanisms driving mTORC2 activation independent of growth factors.
Conclusions:
- Understanding mTORC2's localization and activation mechanisms is crucial for deciphering its role in cellular processes.
- Further investigation into growth factor-independent activation pathways will reveal new therapeutic targets.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

